VDRM logo

ViaDerma, Inc. Stock Price

OTCPK:VDRM Community·US$493.5k Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

VDRM Share Price Performance

US$0.0004
-0.01 (-97.33%)
US$0.0004
-0.01 (-97.33%)
Price US$0.0004

VDRM Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

ViaDerma, Inc. Key Details

US$44.7k

Revenue

US$7.1k

Cost of Revenue

US$37.6k

Gross Profit

US$1.6m

Other Expenses

-US$1.5m

Earnings

Last Reported Earnings
Dec 31, 2017
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About VDRM

Founded
2007
Employees
n/a
CEO
Christopher Otiko
WebsiteView website
viaderma.com

ViaDerma, Inc., through its subsidiary, manufactures and sells pharmaceutical related products in the United States. The company’s lead product is Vitastem, a tetracycline and topical delivery technology for antibiotics to pain relief, skincare, and other. It is also developing various products for vitiligo, psoriasis, eczema, and other skin conditions using SkinPass topical delivery system, as well as antifungal, cosmetics, and pain management products. In addition, company develops anti-aging skin care, pain management, hair-loss, and toenail fungus products. It also provides licenses for its technology for pharmaceutical industry in various therapeutic areas. The company was formerly known as Décor Products International, Inc. and changed its name to ViaDerma, Inc. in May 2014. ViaDerma, Inc. was incorporated in 2007 and is headquartered in Las Vegas, Nevada.

Recent VDRM News & Updates

Recent updates

No updates